Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Assessing the Cox model assumption as a statistical tool for classifying lymphomas.

P Morel¹, B Souleau, F Morschhauser

¹Service d' Hématologie Clinique, Centre Hospitalier Schaffner, 62300 Lens, France. pimorel@nordnet.fr

The Hematology Journal : the Official Journal of the European Haematology Association

|March 29, 2002

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study.

Neurobiology of disease·2024

Same author

Does the guidance method affect the doses of botulinum toxin in writer's cramp?

Revue neurologique·2024

Same author

PROPENSIX: pressure garment therapy using compressive dynamic Lycra<sup>®</sup> sleeve to improve bi-manual performance in unilateral cerebral palsy: a multicenter randomized controlled trial protocol.

Trials·2022

Same author

Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?

Revue neurologique·2021

Same author

Long-term outcomes of primary cystocele repair by transvaginal mesh surgery versus laparoscopic mesh sacropexy: extended follow up of the PROSPERE multicentre randomised trial.

BJOG : an international journal of obstetrics and gynaecology·2021

Same author

A re-assessment of the oldest therapsid Raranimus confirms its status as a basal member of the clade and fills Olson's gap.

Die Naturwissenschaften·2021

Mantle cell lymphoma (MCL) patients have shorter survival, but the Cox model indicates a potential for long-term cure. This suggests MCL may not be as aggressive as initially thought, with some patients responding to chemotherapy.

Area of Science:

Oncology
Medical Statistics

Background:

The Cox model is a standard tool for survival analysis in medical research.
Lymphomas can have varying long-term cure rates despite similar survival curves.

Purpose of the Study:

To compare survival outcomes and event-free survival (EFS) in different lymphoma subtypes.
To assess the validity of the Cox proportional hazards model for analyzing rare lymphoma subtypes and determining long-term cure rates.

Main Methods:

Log-rank test was used to compare EFS and survival.
Patient data included 64 with mantle cell lymphoma (MCL), 525 with follicular lymphoma, and 1136 with diffuse centroblastic lymphoma (CB).
Proportional hazards assumption of the Cox model was checked to evaluate hazard rate consistency over time.

Related Experiment Videos

Main Results:

MCL patients showed significantly shorter EFS and survival compared to follicular lymphoma patients.
The proportional hazards assumption held true for MCL versus follicular lymphoma, indicating similar long-term event/death rate distributions.
Hazard ratios were not constant over time for MCL versus CB, due to decreasing late event/death rates in CB.

Conclusions:

Validating Cox model assumptions is crucial for assessing long-term cure rates in rare lymphoma subtypes.
Mantle cell lymphoma, despite shorter overall survival, may not be inherently aggressive, with a curable subset of patients identified.
Chemotherapy may offer curative potential for a portion of MCL patients.